Delivery Order SPE2DB22D1106-SPE2DB25FDKM0
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,458.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567117522 valganciclovir HCL 50 mg/ml 88ml, a specialty medication. The award date is January 31, 2025, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.42 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir HCl, a medication used in the treatment of viral infections. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.03 firm-fixed-price delivery order is for the supply of 88 ml of valganciclovir hydrochloride 50 mg/ml, a medication used to treat cytomegalovirus infections. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,334.51, is for the delivery of 4566708387 units of the medication valganciclovir 450 mg tablets. The contract is a firm fixed-price delivery order, with a completion date of December 13, 2024. The contract was not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order with a ceiling value of $1,111.53 for the supply of valganciclovir hydrochloride 50 mg/mL oral solution. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military treatment programs and facilities. The delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,012.82 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir hydrochloride, a medication used to prevent cytomegalovirus (CMV) infection in transplant recipients. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award is for the delivery of 60 tablets of 450 mg Valganciclovir, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,186.10 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 9, 2024 and was awarded on August 8, 2024. This delivery order appears to be part of a larger Indefinite...
This is a $3,851.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,422,066 vials of valganciclovir hydrochloride 50 mg/mL oral solution, with a performance period through March 3, 2025. The contract is not designated as a set-aside and represents an individual order placed under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of 60 tablets of 450 mg valganciclovir to the Defense Logistics Agency (DLA). The contract, valued at $8,903.50, was awarded on December 2, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a performance period ending on December 3, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....